Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
49 studies found for:    "Chromosomal triplication"
Show Display Options
Rank Status Study
1 Completed Non-invasive Chromosomal Examination of Trisomy Study
Condition: Trisomy 21
Intervention:
2 Active, not recruiting Non Invasive Prenatal Diagnosis of Trisomy 21 by Genetic Analysis of Circulating Fetal Cells
Condition: Trisomy 21
Intervention: Other: sample blood
3 Completed Trisomy of Chromosome 21 Diagnosis by High Output Sequencing
Condition: Trisomy 21 - Translocation
Intervention:
4 Active, not recruiting Study of the Efficacy of New Non-invasive Prenatal Tests for Screening for Fetal Trisomies Using Maternal Blood
Conditions: Trisomy 21;   Trisomy 18;   Trisomy 13
Interventions: Other: Integrated prenatal screening for Down's syndrome;   Other: Serum QUAD Assay for aneuploidy screening;   Other: Semiconductor MPSS NIPT assay using ccfDNA in maternal blood;   Other: Optical-based MPSS NIPT assay using ccfDNA in maternal blood;   Other: Harmony™ Test (Ariosa Diagnostics)
5 Recruiting Non-Invasive Chromosomal Evaluation of Trisomy Study
Conditions: Aneuploidy;   Trisomy 21;   Trisomy 18;   Trisomy 13;   Down Syndrome
Intervention:
6 Completed Efficacy and Safety of Oral Rigosertib in Transfusion-dependent, Low or Int-1 or Trisomy 8 Int-2 Myelodysplastic Syndrome
Conditions: Myelodysplastic Syndrome;   MDS;   Trisomy 8
Intervention: Drug: rigosertib
7 Completed Erlotinib for Chemoprevention in Trisomy 7 Positive Primary Sclerosing Cholangitis (PSC)
Conditions: Primary Sclerosing Cholangitis;   Trisomy 7;   Cholangiocarcinoma;   Chemoprevention
Intervention: Drug: Erlotinib (Tarceva)
8 Completed Can Increased Body Mass Index Prevent Adequate Ultrasound Examination for Trisomy 21 Risk Assessment?
Condition: Ultrasound Quality
Intervention: Other: ultrasound
9 Recruiting Diagnosis Accuracy of Noninvasive Screening by PCR Digital for Down Syndrom
Condition: Trisomy 21
Intervention: Genetic: Diagnostic
10 Enrolling by invitation Down Syndrome Screening Based on Dried Blood Spots and Cell-free Fetal DNA
Condition: Trisomy 21
Intervention: Procedure: cell-free fetal DNA
11 Active, not recruiting T21,18 and 13 Screening by Cell Free Fetal DNA in Low Risk Patients
Condition: Trisomy 21, 18 and 13 Screening
Interventions: Device: Genetic NIPT;   Biological: Regular serum screening
12 Recruiting Trisomy 21 in Adulthood
Condition: Down Syndrome
Intervention: Genetic: karyotype
13 Unknown  Fluor Varnish With Silver Nanoparticles for Dental Remineralization in Patients With Trisomy 21
Condition: Down Syndrome
Interventions: Drug: Fluor varnish;   Drug: Fluor varnish with nanoparticles
14 Terminated Infant Weight Gain With Trisomy 21 and CAVC
Condition: Congenital Disorders
Intervention:
15 Completed Clinical Evaluation of the SEQureDx Trisomy Test in Low Risk Pregnancies
Conditions: Aneuploidy;   Down Syndrome;   Noninvasive Prenatal Screening
Intervention: Device: SEQureDx Trisomy Test
16 Completed A New Prenatal Blood Test for Down Syndrome
Conditions: Down Syndrome;   Trisomy 21
Intervention:
17 Recruiting The Human Trisome Project Biobank
Conditions: Down Syndrome;   Trisomy 21
Intervention:
18 Completed Pulmonary Hypertension in Trisomy 21 Patients
Condition: Congenital Disorders
Intervention:
19 Completed Efficacy and Safety of ON 01910.Na in Myelodysplastic Syndrome (MDS) Patients With Trisomy 8 or Classified as Intermediate-1, -2 or High Risk
Condition: Myelodysplastic Syndrome
Intervention: Drug: ON 01910.Na
20 Terminated Detecting Early Onset Pre-eclampsia and Use of Placental Growth Factor (PlGF) for Marker of Trisomy 21
Condition: Pregnancy
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.